2 completed, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Unknown 1 |
Follow Bladder Outlet Obstruction: new trials by email Literature Review of Bladder Outlet Obstruction trials Research Report on Bladder Outlet Obstruction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer Anatomical Endoscpic enucleation of the Prostate - Prostate Cancer Stage I, Bladder Outlet Obstruction | Phase 4 | Unknown | Mansoura University | 50 | 2015-01-01 | 2022-11-30 |
| Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1 Detrusitol 4 mg QD, Doxazosin 4 mg QD - Bladder Outlet Obstruction | Phase 4 | Completed | Buddhist Tzu Chi General Hospital | 395 | 2012-08-01 | 2014-06-25 |
| An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia Toviaz (Fesoterodine) - Bladder Outlet Obstruction | Phase 4 | Completed | Weill Medical College of Cornell University | 17 | 2010-01-01 | 2018-04-10 |
Urinary Bladder Neck Obstruction (3) · Lower Urinary Tract Symptoms (1) · Prostatic Neoplasms (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Urethral Diseases (3) · Urethral Obstruction (3) · Urinary Bladder Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Neoplasms (1) · Neoplasms by Site (1) · Pathological Conditions, Signs and Symptoms (1) · Prostatic Diseases (1)
Doxazosin (1) · Tolterodine Tartrate (1) · fesoterodine (1)
Buddhist Tzu Chi General Hospital (1) · Mansoura University (1) · Weill Medical College of Cornell University (1)
Egypt (1) · Taiwan (1) · United States (1)
Ahmed Elshal, MD (1) · Alexis Te, MD (1) · Hann-Chorng Kuo, M.D. (1)